Welcome to our dedicated page for Fosun Internatio news (Ticker: FOSUY), a resource for investors and traders seeking the latest updates and insights on Fosun Internatio stock.
Fosun International (FOSUY) maintains a dynamic presence across global markets through strategic operations in pharmaceuticals, tourism, insurance, and technology. This news hub provides investors and stakeholders with direct access to official corporate communications and verified market updates.
Discover timely announcements including earnings disclosures, partnership developments, and innovation milestones. Our curated collection features Fosun's latest progress in asset-light strategies, R&D breakthroughs, and global expansion initiatives without editorial commentary.
Key updates cover financial performance metrics, sustainability efforts, leadership changes, and regulatory filings. All content is sourced from Fosun's investor relations team and reputable financial news services to ensure accuracy and compliance.
Bookmark this page for streamlined tracking of Fosun's evolving position in consumer healthcare, luxury tourism, and fintech sectors. Check regularly for essential updates impacting one of Asia's most diversified multinational conglomerates.
Fosun International Limited (OTC:FOSUY) has completed the sale of its 99.743% stake in German private bank Hauck Aufhäuser Lampe Privatbank AG (HAL) for EUR670 million. The transaction, completed on June 30, 2025, delivered a double-digit internal rate of return (IRR) for Fosun.
While divesting HAL's banking business, Fosun retains full ownership of Hauck & Aufhäuser Fund Services S.A. (HAFS), its valuable asset servicing business that manages over EUR100 billion in assets across Luxembourg, Ireland, and German-speaking regions. HAFS will continue collaborating with HAL for fund administration services.
This strategic move aligns with Fosun's asset-light operating strategy and focus on core businesses. The company plans to increase investments in key sectors including biopharmaceuticals, cultural tourism, insurance, and healthcare, while pursuing its goal of achieving RMB10 billion in annual profits.
Fosun International (OTC:FOSUY) has received five prestigious awards from Corporate Governance Asia, including recognition for its Co-CEOs and corporate sustainability efforts. Executive Directors and Co-CEOs Chen Qiyu and Xu Xiaoliang were both honored with Asia's Best CEO awards, while the company secured the Sustainable Asia Award 2025, Best Environmental Responsibility Award, and Best Corporate Communications Award.
The company has demonstrated significant achievements in ESG initiatives, maintaining an MSCI ESG rating of AA and ranking in the top 5% among global peers in S&P Global's Corporate Sustainability Assessment. Fosun has committed to reaching carbon neutrality by 2050 and achieving peak carbon emissions by 2028.
In healthcare innovation, the company reported that its drug HANSIZHUANG received European Union approval in early 2025 as the first PD-1 innovative drug for first-line treatment of extensive-stage small cell lung cancer. Additionally, Fosun's artesunate injection has treated over 80 million severe malaria patients globally, while its CAR-T cell therapy has benefited more than 800 lymphoma patients in mainland China.
Fosun International (FOSUY) has released its 2024 ESG Report and third Climate Information Disclosures Report, highlighting its commitment to sustainable development. The company maintained an MSCI ESG rating of AA and ranked in the top 5% among global peers in S&P Global's Corporate Sustainability Assessment.
The company has established concrete climate goals, aiming to peak carbon emissions by 2028 and achieve carbon neutrality by 2050. Notable achievements include completing a USD888 million sustainability-linked syndicated loan and maintaining LEED Platinum certification for the Bund Finance Center in Shanghai.
In healthcare innovation, Fosun's anticancer drug HANSIZHUANG received EU approval for small cell lung cancer treatment, while their artesunate injection has treated over 80 million severe malaria patients globally. The company's total assets reached RMB796.5 billion as of December 2024.
Nanyang Commercial Bank (NCB) and Fosun International (HKEX: 00656) have signed a strategic cooperation agreement on April 24, 2025, marking a new milestone in their 15-year partnership that began in 2010. The agreement aims to strengthen their financial collaboration, with NCB providing comprehensive banking services to support Fosun's future development.
NCB will leverage its cross-border operations expertise while integrating with Fosun's global presence in over 35 countries. The partnership focuses on developing products and services based on complementary advantages and mutual benefits. The agreement was signed at NCB's Hong Kong headquarters, attended by key executives from both companies including Sun Jiandong, Wang Qunbin, and Gong Ping.
Fosun International (HKEX: 00656) has achieved a significant milestone by ranking in the top 1% of S&P Global's Sustainability Yearbook 2025 (China Edition) for the second consecutive year. The company scored 70 in the 2024 S&P Global CSA, outperforming the industry average by approximately 40 points.
Out of more than 1,600 Chinese companies assessed, only about 160 made it to the Yearbook, requiring scores within the top 15% of their industry and a minimum CSA score of 60. Fosun currently ranks among the top 5% of global peers in the CSA.
The company maintains strong ESG credentials, including an MSCI ESG rating of AA since 2021, an HSI ESG rating of AA-, and consistent inclusion in the Hang Seng Corporate Sustainability Benchmark Index. Fosun's commitment to sustainability extends to philanthropy projects in rural revitalization, healthcare, educational equity, and community development.
Fosun International showcased its commitment to the Hainan Free Trade Port (FTP) development at the 2025 Global Investment Promotion Conference. Co-Chairman Wang Qunbin highlighted the company's 20-year presence in Hainan, creating over 6,000 jobs and contributing RMB10 billion in tax revenue.
Key achievements include:
- The Atlantis Sanya resort, which has attracted 27 million visitors
- Hainan Mining's successful expansion with lithium mines in Mali and oil fields in Oman, achieving RMB706 million net profit in 2024 (12.97% YoY increase)
- Eight models of Breas Medical ventilators achieving 'Made in Hainan' status
Future initiatives include developing an AI-themed resort, launching a 20,000-ton annual capacity lithium hydroxide facility with RMB1 billion investment, and expanding healthcare services through the Rural Doctors Program across five locations.
Finloop, an AI-driven institutional wealth management platform under Fosun Wealth Holdings, has been selected as a strategic enterprise by Hong Kong's Office for Attracting Strategic Enterprises (OASES). The company joined 17 other enterprises in signing partnership agreements with the government on April 8, 2025.
Having established its headquarters in Hong Kong in 2024 and becoming a Cyberport tenant in March 2025, Finloop provides comprehensive wealth management solutions including cash management, funds, structured products, bonds, insurance, and virtual assets. The platform features three AI-powered systems: AI Product Manager, AI Investment Advisor, and AI Assistant.
Finloop has positioned itself as a key provider for Cross-boundary Wealth Management Connect 1.0 and 2.0, while also offering solutions for virtual asset ETFs and stablecoin dealings. The company aims to strengthen Hong Kong's position in RWA tokenization and plans to expand throughout the Asia-Pacific region.
Fosun International (FOSUY) reported its 2024 annual results with total revenue of RMB192.14 billion and industrial operation profit of RMB4.9 billion. The company recorded a loss of RMB4.35 billion attributable to owners, primarily due to a non-cash impairment loss from Cainiao investment. Excluding this adjustment, profit was RMB750 million.
Key highlights include:
- Overseas revenue increased from 45% to 49.3%
- Technology innovation investment reached RMB6.9 billion
- Interest-bearing debt stands at over RMB80 billion
The company aims to:
- Double industrial operation profit to RMB10 billion
- Reduce debt to RMB60 billion
- Increase dividend payout ratio
- Achieve investment grade credit ratings
Fosun International (FOSUY) held its 2024 annual results presentation, reporting total revenue of RMB192.14 billion and industrial operation profit of RMB4.9 billion. The company recorded a loss of RMB4.35 billion attributable to owners, primarily due to Cainiao investment value adjustment. Excluding this adjustment, profit was RMB750 million.
Chairman Guo Guangchang emphasized that the financial adjustment was not due to operational issues, highlighting that core businesses remain healthy. The company's overseas revenue comprised 49.3% of total revenue in 2024. Fosun aims to reduce interest-bearing debts from RMB80+ billion to RMB60 billion and targets RMB10 billion in both industrial operation profit and profit attributable to owners in the future.
The company continues its strategy of divesting heavy assets while advancing in innovative industries. Notable developments include the privatization of Fosun Tourism Group, while attempts to privatize Henlius were unsuccessful due to minority shareholder opposition.
FAQ
What is the current stock price of Fosun Internatio (FOSUY)?
What is the market cap of Fosun Internatio (FOSUY)?
